English
简体中文
繁體中文
English
Filipino
हिन्दी
Hmong
Bahasa Indonesia
日本語
Basa Jawa
한국어
ພາສາລາວ
Bahasa Melayu
മലയാളം
ဗမာစာ
سنڌي
தமிழ்
ไทย
Tiếng Việt
Afrikaans
Shqip
العربية
አማርኛ
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
Corsu
Italiano
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Suomi
Frysk
Galego
ქართული
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Deutsch
Français
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
Magyar
Íslenska
Igbo
Gaeilge
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
كوردی
Кыргызча
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Maltese
Te Reo Māori
मराठी
Монгол
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
తెలుగు
Türkçe
Українська
اردو
O‘zbekcha
Cymraeg
isiXhosa
יידיש
Yorùbá
ZuluSWITZERLAND: Earlier this year, Neoss Group joined forces with Osstell AB, a global pioneer in implant stability measurement and osseointegration progress monitoring. The new partnership has now introduced NeoTell, an innovative device designed for swift, precise, and cost-effective implant stability measurement. NeoTell promises to empower clinicians with the tools needed to enhance patient outcomes while simplifying the digital workflow.
Product of Expertise and Collaboration
NeoTell represents a fusion of Neoss Group’s user-friendly dental implant solutions with Osstell’s extensive knowledge in implant stability and osseointegration.
Dr. Robert Gottlander, President and CEO of the Neoss Group, shared his optimism, stating, “NeoTell will offer clinicians the means to work more efficiently and effectively. Our collaboration with Osstell ensures that we can provide the dental community with a comprehensive solution that enhances the predictability and success of dental implant procedures. We believe that NeoTell will become an indispensable tool for dental professionals.”
NeoTell provides dental professionals with an intuitive, user-friendly device capable of delivering objective results without resorting to invasive procedures. This technology enables clinicians to make informed treatment decisions swiftly and with confidence.
Affordability and Accessibility
One standout feature of NeoTell is its affordability, which brings RFA (Resonance Frequency Analysis) technology within reach of a wider range of dental practitioners. The cost-effectiveness of NeoTell ensures that more clinicians can harness the advantages of RFA technology. Patients, in turn, can anticipate improved outcomes due to more precise assessments and treatment planning. Ultimately, this leads to greater confidence and satisfaction in dental implant procedures.
To delve deeper into NeoTell and its potential to transform implant stability measurement in the dental field, please visit Neoss Group’s official website.
Click for more information about the NeoTell by Neoss.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.